Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide

Lenalidomide is clinically active in chronic lymphocytic leukemia (CLL), but its effectiveness in the context of the CLL mutational landscape is unknown. We performed targeted capture sequencing of 295 cancer genes in specimens from 102 CLL patients with treatment-naïve disease (TN patients) and 186...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood
Egile Nagusiak: Takahashi, Koichi, Hu, Boyu, Wang, Feng, Yan, Yuanqing, Kim, Ekaterina, Vitale, Candida, Patel, Keyur P., Strati, Paolo, Gumbs, Curtis, Little, Latasha, Tippen, Samantha, Song, Xingzhi, Zhang, Jianhua, Jain, Nitin, Thompson, Philip, Garcia-Manero, Guillermo, Kantarjian, Hagop, Estrov, Zeev, Do, Kim-Anh, Keating, Michael, Burger, Jan A., Wierda, William G., Futreal, P. Andrew, Ferrajoli, Alessandra
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2018
Gaiak:
Lymphoid Neoplasia
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5909764/
https://ncbi.nlm.nih.gov/pubmed/29358183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-11-817296
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak